Verified By Apollo Pulmonologist May 6, 2020
2668Antibiotics do not work against viruses, but there are some scenarios for using antibiotics in some patients with COVID-19. One reason may be that patients with COVID -19 pneumonia can develop a secondary bacterial infection that may need to be treated with an antibiotic.
Azithromycin is also thought to have antiviral and anti-inflammatory activity and may work synergistically with other antiviral treatments and is being studied currently.
Clinical trials have commenced evaluating if gimsilumab, an artificially synthesized antibody can reduce death risk among patients with Covid-19. Covid-19 patients develop an excessive immune response causing acute respiratory distress syndrome (ARDS) and death. Gimsilumab is a monoclonal antibody that attacks the granulocyte macrophage-colony stimulating factor (GM-CSF), a key driver of lung hyper-inflammation.
The content is verified and reviewd by experienced practicing Pulmonologist to ensure that the information provided is current, accurate and above all, patient-focused
April 12, 2021
January 16, 2021
December 24, 2020